Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 84 citing McMahon: Antibody levels and protection after hepatitis B vaccination: results of a 15-year.... (0.09 sec) 

Immunologic responses following administration of a vaccine targeting human papillomavirus …

- umb.edu [PDF] 
LL Villa, KA Ault, AR Giuliano, RLR Costa, … - Vaccine, 2006 - Elsevier
Human papillomavirus (HPV) infection causes cervical cancer and genital warts.
Young women (1106) were randomized to receive one of three formulations of a
quadrivalent HPV (Types 6/11/16/18) L1 virus-like particle (VLP) vaccine or ...
Cited by 248 - Related articles - All 6 versions

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian …

- iss.it [PDF] 
AR Zanetti, A Mariano, L Romanò, R D'Amelio … - The Lancet, 2005 - Elsevier
In 1212 children and 446 Italian Air Force recruits vaccinated as infants and
adolescents, respectively, we measured the concentrations of antibodies to
hepatitis-B surface antigen (anti-HBs) and the presence of antibodies to ...
Cited by 86 - Related articles - All 13 versions

A mathematical model to estimate global hepatitis B disease burden and vaccination impact

- oxfordjournals.org
ST Goldstein, F Zhou, SC Hadler, BP Bell, EE … - International journal of epidemiology, 2005 - IEA
Methods A model was developed to calculate the age-specific risk of acquiring
HBV infection, acute hepatitis B (illness and death), and progression to chronic
HBV infection. HBV-related deaths among chronically infected persons were ...
Cited by 88 - Related articles - BL Direct - All 9 versions

Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future …


YH Ni, LM Huang, MH Chang, CJ Yen, CY Lu, … - Gastroenterology, 2007 - Elsevier
Background & Aims: Following the world's first successful implementation of a
universal hepatitis B virus (HBV) vaccination program for infants in Taiwan 20
years ago, we performed this study to evaluate the long-term protection ...
Cited by 50 - Related articles - BL Direct - All 29 versions

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus …


D FitzSimons, G François, A Hall, B McMahon … - Vaccine, 2005 - Elsevier
In March 2004, the Viral Hepatitis Prevention Board (VHPB) convened a meeting in
Sevilla, Spain, in order that experts from Canada, Europe, Israel, Saudi Arabia,
Taiwan, Turkey, and United States of America could review long-term ...
Cited by 42 - Related articles - All 4 versions

Persistence of antibody to hepatitis B and protection from disease among Alaska natives …


CM Dentinger, BJ McMahon, JC Butler, CE … - The Pediatric infectious disease journal, 2005 - journals.lww.com
Catherine M. Dentinger, FNP, MS,* Brian J. McMahon, MD,† Jay C. Butler, MD,*
Charlotte E. Dunaway,* Carolyn L. Zanis, BS,* Lisa R. Bulkow, MS,* Dana L.
Bruden, MS,* Omana V. Nainan, PhD,‡ Marina L. Khristova, PhD,‡ Thomas ...
Cited by 34 - Related articles - All 4 versions

[PDF] EUROPEAN RECOMMENDATIONS FOR THE MANAGEMENT OF HEALTHCARE …


V Puro, G De Carli, S Cicalini, F Soldani, U … - Euro Surveill, 2005 - sbinfecto.org.br
Exposure prevention is the primary strategy to reduce the risk of occupational
bloodborne pathogen infections in healthcare workers (HCW). HCWs should be made
aware of the medicolegal and clinical relevance of reporting an exposure, ...
Cited by 26 - Related articles - View as HTML - All 7 versions

Antibody response to hepatitis B vaccine in end-stage renal disease patients


KM Chow, MC Law, CB Leung, CC Szeto, PKT … - Nephron Clin Pract, 2006 - content.karger.com
Background: This retrospective and comparative study evaluated the relationship
between different factors which may contribute to suboptimal immunological
response to intramuscular recombinant hepatitis B vaccine in end-stage ...
Cited by 23 - Related articles - BL Direct - All 4 versions

Long-term protection against carriage of hepatitis B virus after infant vaccination

- openrepository.com [PDF] 
MAB Sande, P Waight, M Mendy, P Rayco-Solon, … - The Journal of infectious diseases, 2006 - UChicago Press
Featured in US News & World Report "Common Cold Virus Alters Body's Genes"
October 24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory
Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine ...
Cited by 23 - Related articles - BL Direct - All 8 versions

Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination


MH Sjogren - The American journal of medicine, 2005 - Elsevier
Although vaccination against hepatitis B virus (HBV) is highly successful, 5% to
10% of individuals do not experience a response with an adequate antibody level
to hepatitis B surface antigen (anti-HBs). Contributing causes for ...
Cited by 22 - Related articles - All 12 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google